Mirae Asset Global Etfs Holdings Ltd. Dia Medica Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,425 shares of DMAC stock, worth $101,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,425Holding current value
$101,552% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DMAC
# of Institutions
59Shares Held
6.12MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$10.8 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$4.58 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$4.44 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$4.27 Million0.01% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.69 Million0.47% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $186M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...